Initial central venous pressure could be a prognostic marker for hemodynamic improvement of polymyxin B direct hemoperfusion: A retrospective cohort study

Journal of Intensive Care

Volumn 4, Issue 1, 2016, Pages

  Yamada, Hiroyuki ^a,b   Tsukamoto, Tatsuo ^a   Narumiya, Hiromichi ^b   Oda, Kazumasa ^b   Higaki, Satoshi ^b   Iizuka, Ryoji ^b   Yanagita, Motoko ^a   Deguchi, Masako ^b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO SECOND RED CROSS HOSPITAL   (Japan)

Author keywords

Central venous pressure; Hemoperfusion; PMX DHP; Polymyxin B; Septic shock

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; DOPAMINE; ENDOTOXIN; HEMOGLOBIN; LACTIC ACID; LOW MOLECULAR WEIGHT HEPARIN; NAFAMSTAT MESILATE; NORADRENALIN; POLYMYXIN B; PROTEIN;

AGED; APACHE; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY TEMPERATURE; CARDIOVASCULAR PARAMETERS; CENTRAL VENOUS PRESSURE; COHORT ANALYSIS; EARLY GOAL DIRECTED THERAPY; FEMALE; FRACTIONAL INSPIRED OXYGEN; GRAM NEGATIVE BACTERIUM; HEART INDEX; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HEMOPERFUSION; HUMAN; INFECTION; INFUSION RATE; INOTROPISM; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL PROCEDURES; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVAL RATE; THROMBOCYTE COUNT; VASOPRESSOR DEPENDENCY INDEX;

EID: 84997241520     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/s40560-016-0186-8     Document Type: Article

References (29)

1. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368-77.
2. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign. Crit Care Med. 2013;41(2):580-637.
3. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564-75.
4. Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422-7.
5. Boyd JH, Forbes J, Nakada T-a, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality*. Crit Care Med. 2011;39(2):259-65.
6. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147-239.
7. Tsai YC, Tsai JC, Chen SC, et al. Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis. 2014;63(1):68-75.
8. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (toraymyxin). Ther Apher Dial. 2003;7(1):108-14.
9. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301(23):2445-52.
10. Berto P, Ronco C, Cruz D, Melotti RM, Antonelli M. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy. Blood Purif. 2011;32(4):331-40.
11. Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007;11(2):R47.
12. Payen DM, Guilhot J, Launey Y, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41(6):975-84.
13. Hoffman MJ, Greenfield LJ, Sugerman HJ, Tatum JL. Unsuspected right ventricular dysfunction in shock and sepsis. Ann Surg. 1983;198(3):307-19.
14. Marik PE, Cavallazzi R. Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense*. Crit Care Med. 2013;41(7):1774-81.
15. Van Biesen W, Yegenaga I, Vanholder R, et al. Relationship between fluid status and its management on acute renal failure (ARF) in intensive care unit (ICU) patients with sepsis: a prospective analysis. J Nephrol. 2005;18(1):54-60.
16. Magder S. Central venous pressure: a useful but not so simple measurement. Crit Care Med. 2006;34(8):2224-7.
17. Magder S, Bafaqeeh F. The clinical role of central venous pressure measurements. J Intensive Care Med. 2007;22(1):44-51.
18. Kobayashi A, Iwasaki Y, Kimura Y, Kawagoe Y, Ujike Y. Early recovery in hemodynamics after direct hemoperfusion with polymyxin B-immobilized fibers may predict mortality rate in patients with septic shock. J Anesth. 2010;24(5):709-15.
19. Gelman S. Venous function and central venous pressure: a physiologic story. Anesthesiology. 2008;108(4):735-48.
20. Magder S. Bench-to-bedside review: an approach to hemodynamic monitoring-Guyton at the bedside. Crit Care. 2012;16(5):236.
21. Marik PE. Iatrogenic salt water drowning and the hazards of a high central venous pressure. Ann Intensive Care. 2014;4:21.
22. Henderson WR, Griesdale DE, Walley KR, Sheel AW. Clinical review: Guyton-the role of mean circulatory filling pressure and right atrial pressure in controlling cardiac output. Crit Care. 2010;14(6):1.
23. Ikeda T, Ikeda K, Nagura M, et al. Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure. Ther Apher Dial. 2004;8(4):293-8.
24. Nishibori M, Takahashi HK, Katayama H, et al. Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Med Okayama. 2009;63(1):65-9.
25. Kohro S, Imaizumi H, Yamakage M, et al. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. J Anesth. 2006;20(1):11-6.
26. Takeyama N, Noguchi H, Hirakawa A, et al. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients. Blood Purif. 2012;33(4):252-6.
27. Yamashita C, Hara Y, Kuriyama N, Nakamura T, Nishida O. Clinical effects of a longer duration of polymyxin B-immobilized fiber column direct hemoperfusion therapy for severe sepsis and septic shock. Ther Apher Dial. 2015;19(4):316-23.
28. Wang XT, Yao B, Liu DW, Zhang HM. Central venous pressure dropped early is associated with organ function and prognosis in septic shock patients: a retrospective observational study. Shock. 2015;44(5):426-30.
29. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53(7):582-8.